Literature DB >> 628353

A rapid method for the determination of glycosylated hemoglobins using high pressure liquid chromatography.

R A Cole, J S Soeldner, P J Dunn, H F Bunn.   

Abstract

Hemoglobin (Hb) Alc is a minor component of Hb found in normal individuals but elevated two or threefold in patients with diabetes mellitus. Limited studies have suggested that the level of Hb Alc is proportional to the integrated concentration of glucose over time. Thus it could serve as an index of hyperglycemia. Its measurement may enable a more objective approach to assessing whether or not the control of hyperglycemia can be correlated with the severity of complications of diabetes. Large scale clinicab studies of Hb Alc have not been undertaken for lack of a rapid assay system. This article describes a method of high pressure liquid chromatography (HPLC) which enables the isolation of Hb Alc in 27 min using only 12 microgram of Hb (100 microliter of blood) and a second method for the isolation of total fast Hb components (also elevated in diabetes) in 11 min. Using the first method, a total of 36 assays were performed on the blood of a single normal volunteer over a one month period. the mean level of Hb Alc was 4.95 +/- 0.12% (SD) +/- 0.02% (SEM), while the coefficient of variation (C.V.) was 2.4%. The mean Hb Alc & b level was 1.65 +/- 0.06% +/- 0.01% (C.V. = 3.6%). Values for Hb Alc in 10 normal individuals were 5.06 (mean) +/- 0.32% (SD) +/- 0.01% (SEM). Hb Alc values in 15 patients with diabetes mellitus ranged from 6.8 to 20.0%. The second method was designed to assay Hb Ala, Hb Alb, and Hb Alc as a single peak and yielded results identical to the sum of these components as determined by the first method ( r = 0.98; p less than 0.001).

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 628353     DOI: 10.1016/0026-0495(78)90109-9

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  28 in total

1.  Soluble CD8 antigen, stimulated C-peptide and islet cell antibodies are predictors of insulin requirement in newly diagnosed patients with unclassifiable diabetes.

Authors:  P Di Bonito; A De Bellis; B Capaldo; S Turco; G Corigliano; E Pace; A Bizzarro
Journal:  Acta Diabetol       Date:  1996-09       Impact factor: 4.280

2.  HbA1 in assessment of metabolic control in diabetic BB/E rats.

Authors:  F J Tames; J D Baird; A J Bone
Journal:  Diabetologia       Date:  1990-05       Impact factor: 10.122

3.  Serum fructosamine concentrations in patients with type II (non-insulin-dependent) diabetes mellitus during changes in management.

Authors:  J R Baker; R N Johnson; D J Scott
Journal:  Br Med J (Clin Res Ed)       Date:  1984-05-19

4.  Serum total renin, an independent marker of the activity and severity of retinopathy in patients with IDDM.

Authors:  S Mäkimattila; P Summanen; I Matinlauri; M Mäntysaari; A Schlenzka; M Aalto; K Irjala; H Yki-Järvinen
Journal:  Br J Ophthalmol       Date:  1998-08       Impact factor: 4.638

5.  Insulin increases plasma leptin concentrations in normal subjects and patients with NIDDM.

Authors:  R Malmström; M R Taskinen; S L Karonen; H Yki-Järvinen
Journal:  Diabetologia       Date:  1996-08       Impact factor: 10.122

6.  Clinical importance of the reversible fraction of haemoglobin A1c in Type 2 (non-insulin-dependent) diabetes.

Authors:  D R Jury; J R Baker; P J Dunn
Journal:  Diabetologia       Date:  1983-10       Impact factor: 10.122

7.  Clinical usefulness of estimation of serum fructosamine concentration as a screening test for diabetes mellitus.

Authors:  J R Baker; J P O'Connor; P A Metcalf; M R Lawson; R N Johnson
Journal:  Br Med J (Clin Res Ed)       Date:  1983-09-24

8.  Non-enzymatically glycosylated serum protein in diabetes mellitus: an index of short-term glycaemia.

Authors:  L Kennedy; T D Mehl; W J Riley; T J Merimee
Journal:  Diabetologia       Date:  1981-08       Impact factor: 10.122

9.  Swiss hypertension treatment programme with verapamil and/or enalapril in diabetic patients.

Authors:  C Ferrier; P Ferrari; P Weidmann; U Keller; C Beretta-Piccoli; W F Riesen
Journal:  Drugs       Date:  1992       Impact factor: 9.546

10.  Stiffening of connective tissue in elderly diabetic patients: relevance to diabetic nephropathy and oxidative stress.

Authors:  Y Aoki; K Yazaki; K Shirotori; Y Yanagisawa; H Oguchi; K Kiyosawa; S Furuta
Journal:  Diabetologia       Date:  1993-01       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.